Unleashing the potential of combining FGFR inhibitor and immune checkpoint blockade for FGF/FGFR signaling in tumor microenvironment

被引:0
|
作者
Ruiwen Ruan
Li Li
Xuan Li
Chunye Huang
Zhanmin Zhang
Hongguang Zhong
Shaocheng Zeng
Qianqian Shi
Yang Xia
Qinru Zeng
Qin Wen
Jingyi Chen
Xiaofeng Dai
Jianping Xiong
Xiaojun Xiang
Wan Lei
Jun Deng
机构
[1] First Affiliated Hospital of Nanchang University,Department of Oncology
[2] Jiangxi Key Laboratory for lndividualized Cancer Therapy,undefined
来源
Molecular Cancer | / 22卷
关键词
Fibroblast growth factor receptor; Immune checkpoint blockade; Tumor microenvironment; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Ablative Radiotherapy Reprograms the Tumor Microenvironment of a Pancreatic Tumor in Favoring the Immune Checkpoint Blockade Therapy
    Lee, Yu-Hung
    Yu, Ching-Fang
    Yang, Ying-Chieh
    Hong, Ji-Hong
    Chiang, Chi-Shiun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (04) : 1 - 14
  • [22] Longitudinal Tumor Microenvironment Analysis in Extensive Stage SCLC Patients Treated with Dual Checkpoint Inhibitor Blockade
    Chiang, A.
    Matera, R.
    Ashley, K.
    Rajendran, B. K.
    Schalper, K. A.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S362 - S362
  • [23] The tumor microenvironment of pancreatic adenocarcinoma and immune checkpoint inhibitor resistance: a perplex relationship
    Sahin, Irem
    Turen, Sevda
    Santapuram, Pranav
    Sahin, Ibrahim Halil
    CANCER DRUG RESISTANCE, 2020, 3 (04) : 699 - 709
  • [24] Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade
    Zhao, Xinrui
    Shao, Chunlin
    CANCERS, 2020, 12 (10) : 1 - 20
  • [25] Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response
    Ahmed, Kazi Mokim
    Veeramachaneni, Ratna
    Deng, Defeng
    Putluri, Nagireddy
    Putluri, Vasanta
    Cardenas, Maria F.
    Wheeler, David A.
    Decker, William K.
    Frederick, Andy, I
    Kazi, Sawad
    Sikora, Andrew G.
    Sandulache, Vlad C.
    Frederick, Mitchell J.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (08)
  • [26] NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells
    Takase, Nobuhisa
    Koma, Yu-ichiro
    Urakawa, Naoki
    Nishio, Mari
    Arai, Noriaki
    Akiyama, Hiroaki
    Shigeoka, Manabu
    Kakeji, Yoshihiro
    Yokozaki, Hiroshi
    CANCER LETTERS, 2016, 380 (01) : 47 - 58
  • [27] Recent advances in tumor microenvironment-targeted nanomedicine delivery approaches to overcome limitations of immune checkpoint blockade-based immunotherapy
    Kim, Jaehyun
    Hong, Juhyeong
    Lee, Jieun
    Lahiji, Shayan Fakhraei
    Kim, Yong-Hee
    JOURNAL OF CONTROLLED RELEASE, 2021, 332 : 109 - 126
  • [28] Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
    Abe, Shinya
    Nagata, Hiroshi
    Crosby, Erika J.
    Inoue, Yoshiyuki
    Kaneko, Kensuke
    Liu, Cong-Xiao
    Yang, Xiao
    Wang, Tao
    Acharya, Chaitanya R.
    Agarwal, Pankaj
    Snyder, Joshua
    Gwin, William
    Morse, Michael A.
    Zhong, Pei
    Lyerly, Herbert Kim
    Osada, Takuya
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [29] Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer
    Pingili, Ajeeth K.
    Chaib, Mehdi
    Sipe, Laura M.
    Miller, Emily J.
    Teng, Bin
    Sharma, Rahul
    Yarbro, Johnathan R.
    Asemota, Sarah
    Al Abdallah, Qusai
    Mims, Tahliyah S.
    Marion, Tony N.
    Daria, Deidre
    Sekhri, Radhika
    Hamilton, Alina M.
    Troester, Melissa A.
    Jo, Heejoon
    Choi, Hyo Young
    Hayes, D. Neil
    Cook, Katherine L.
    Narayanan, Ramesh
    Pierre, Joseph F.
    Makowski, Liza
    CELL REPORTS, 2021, 35 (12):
  • [30] Gut Microbiota-Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
    Said, Sawsan Sudqi
    Ibrahim, Wisam Nabeel
    CANCER MANAGEMENT AND RESEARCH, 2025, 17 : 171 - 192